Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity
The Prostate, 11/02/09
Qian DZ et al. – The results support a mechanism of chemotherapy resistance mediated by cellular stress responses involving the induction of CCL2 expression and suggest that inhibiting CCL2 activity could enhance therapeutic responses to taxane–based therapy.
Related Articles
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 72%
Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection
The Journal of Urology, 11/13/09
Relevance Score: 71%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 71%
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
The Prostate, 11/02/09
Relevance Score: 71%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 71%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Is there a learning curve for subureteric injection of dextranomer/hyaluronic acid in the treatment of vesicoureteral reflux?
Journal of Pediatric Urology , 03/19/10
Screening Agents for Preventive Efficacy in a Bladder Cancer Model: Study Design, End Points, and Gefitinib and Naproxen Efficacy
The Journal of Urology, 03/18/10
Current therapy of acute uncomplicated cystitis
International Journal of Urology, 03/18/10
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine
Discovery Medicine, 03/19/10
Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells
Oncogene, 03/19/10
Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
Archives of Internal Medicine, 03/19/10
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine
Discovery Medicine, 03/19/10
Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells
Oncogene, 03/19/10
Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
Archives of Internal Medicine, 03/19/10
Article Search
Sponsor


See Latest Articles


